Liposome Technology for Industrial Purposes
Journal of Drug Delivery · 05.12.2011 · 2011 · 1-9
DOI: 10.1155/2011/591325 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drug Delivery, erschienen am 05.12.2011. Verfasst von Andreas Wagner und 1 weiteren Autor:innen. Beteiligte Einrichtung: Polymun Scientific Immunbiologische Forschung GmbH, Nu β dorfer Lände 11, 1190 Vienna, Austria. Die Arbeit wurde bisher 323-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Liposomes, spherical vesicles consisting of one or more phospholipid bilayers, were first described in the mid 60s by Bangham and coworkers. Since then, liposomes have made their way to the market. Today, numerous lab scale but only a few large-scale techniques are available. However, a lot of these methods have serious limitations in terms of entrapment of sensitive molecules due to their exposure to mechanical and/or chemical stress. This paper summarizes exclusively scalable techniques and focuses on strengths, respectively, limitations in respect to industrial applicability. An additional point of view was taken to regulatory requirements concerning liposomal drug formulations based on FDA and EMEA documents.
Autor:innen und Institutionen
- Polymun Scientific Immunbiologische Forschung GmbH, Nu β dorfer Lände 11, 1190 Vienna, Austria.
Zitieren
APA
Wagner, A., & Vorauer-Uhl, K. (2011). Liposome Technology for Industrial Purposes. Journal of Drug Delivery, 2011, 1-9. https://doi.org/10.1155/2011/591325
Vancouver
Wagner A, Vorauer-Uhl K. Liposome Technology for Industrial Purposes. Journal of Drug Delivery. 2011;2011:1-9. doi:10.1155/2011/591325
BibTeX
@article{Wagner2011,
author = {Wagner, Andreas and Vorauer-Uhl, Karola},
title = {Liposome Technology for Industrial Purposes},
journal = {Journal of Drug Delivery},
year = {2011},
volume = {2011},
pages = {1--9},
doi = {10.1155/2011/591325}
}
EUVIMED